A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)

BACKGROUND: New-onset refractory status epilepticus (NORSE) is a newly defined critical disease entity characterized by prolonged periods of refractory epileptic seizure with no readily identifiable cause in otherwise healthy individuals. Its etiology is uncertain, but autoimmune encephalitis is a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodama, Satoshi, Arai, Noritoshi, Hagiwara, Akiyoshi, Kimura, Akio, Takeuchi, Sousuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069820/
https://www.ncbi.nlm.nih.gov/pubmed/30083346
http://dx.doi.org/10.1186/s40560-018-0315-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069820/
https://www.ncbi.nlm.nih.gov/pubmed/30083346
http://dx.doi.org/10.1186/s40560-018-0315-7

Ejemplares similares